These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37220545)

  • 1. Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, China.
    Xia H; Jin J; Ba H; Zhang Y; Li J; Guo R; Li Y; Ma P; Zhang Y
    Drug Des Devel Ther; 2023; 17():1485-1494. PubMed ID: 37220545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Genetic Diversity and High Prevalence of Pretreatment Drug Resistance in Tianjin, China.
    Zeng R; Ren D; Gong X; Wei M; Gao L; Yu A; Zhang D; Mi Y; Ma P
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):852-861. PubMed ID: 32539490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].
    Xiao PP; Lu J; Hu HY; Xu XQ; Ding P; Fu GF; Huan XP; Zhou Y; Yang HT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):988-993. PubMed ID: 29136743
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023].
    Qin YZ; Shen YL; Liu AW; Wu JJ; Miu LF; Fang Q; Shuai CX; Jin L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Aug; 58(8):1204-1212. PubMed ID: 39142890
    [No Abstract]   [Full Text] [Related]  

  • 6. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular transmission network analysis reveals the challenge of HIV-1 in ageing patients in China: elderly people play a crucial role in the transmission of subtypes and high pretreatment drug resistance in developed Eastern China, 2019-2023.
    Cao D; Xing H; Feng Y; He T; Zhang J; Ling J; Chen J; Zhao J
    Virol J; 2024 Aug; 21(1):199. PubMed ID: 39187869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.
    Liu M; He XQ; Deng RN; Tang SQ; Harypursat V; Lu YQ; He K; Huo Q; Yang HH; Liu Q; Chen YK
    HIV Med; 2022 Mar; 23 Suppl 1(Suppl 1):95-105. PubMed ID: 35293098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.
    Yu G; Li Y; Huang X; Zhou P; Yan J; Yan X; Fu X; Fang Y; Liu J; Li J; He X; Lin P
    Curr HIV Res; 2020; 18(3):210-218. PubMed ID: 32294040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of HIV-1 genetic subtype and pretreatment drug resistance among men who have sex with men infected with HIV-1 from 19 cities of 6 provinces in China].
    Zhang R; Dong TL; Liang WL; Cao ZB; Xie Z; Liu KM; Yu F; Fu GF; Zhang YQ; Wang GY; Ma QQ; Wu SB; Li Y; Dong W; Jiang Z; Xu J; Wu ZY; Yao J; Pan PL; Qiu MF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):523-527. PubMed ID: 35443307
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
    Wang Z; Jiang H; Pang X; Li J; Liang S; Huang J; Li D; Hou W; Chen N; Lan G
    J Antimicrob Chemother; 2024 Oct; 79(10):2575-2585. PubMed ID: 39045823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Diversity, Complicated Recombination, and Deteriorating Drug Resistance Among HIV-1-Infected Individuals in Wuhan, China.
    Zhang Y; Luo Y; Li Y; Zhang Y; Wu W; Peng H; Han L; Chen Y; Ruan L; Yang R
    AIDS Res Hum Retroviruses; 2021 Mar; 37(3):246-251. PubMed ID: 32878449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China.
    Guo J; Yan Y; Zhang J; Ji J; Ge Z; Ge R; Zhang X; Wang H; Chen Z; Luo J
    Oncotarget; 2017 Mar; 8(11):18271-18279. PubMed ID: 28407682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
    Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
    Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.
    Yu D; Liang B; Yang Y; Liu J; Liang H; Zhang F; Jiang J; Huang J; Zhong S; Qin C; Jiang J; Liang H; Ye L
    AIDS Res Hum Retroviruses; 2022 Oct; 38(10):822-830. PubMed ID: 35972723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China.
    Zhang J; Sun B; Sheng Z; Ding X; Fan Q; Huang G; Guo Z; Zhong P; Liao L; Xing H; Xia Y; Chai C; Jiang J
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China.
    Shi P; Chen Z; Meng J; Su M; Yang X; Fan W; Shi H; Gao Y; Lu X
    PLoS One; 2021; 16(12):e0260670. PubMed ID: 34855860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.
    Lan Y; Li L; He X; Hu F; Deng X; Cai W; Li J; Ling X; Fan Q; Cai X; Li L; Li F; Tang X
    Virol J; 2021 Sep; 18(1):181. PubMed ID: 34488793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.